newsfilter
← Latest News
GlobeNewswire·

Moleculin Announces Pricing of $9.3 Million Public Offering

HOUSTON, July 31, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), today announced the pricing of a best-efforts public offering of an aggregate of